Patents Assigned to Seelos Therapeutics, Inc.
  • Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
    Patent number: 10869831
    Abstract: Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: December 22, 2020
    Assignee: Seelos Therapeutics, Inc.
    Inventor: Dalia Megiddo
  • Compositions and methods for treating an aggregation disease or disorder
    Patent number: 10751353
    Abstract: The present invention alleviates a sign or symptom of an aggregation disease or disorder by administering an aqueous formulation comprising trehalose.
    Type: Grant
    Filed: January 31, 2019
    Date of Patent: August 25, 2020
    Assignee: Seelos Therapeutics, Inc.
    Inventor: Dalia Megiddo
  • Treatment of protein aggregation myopathic and neurodegenerative diseases by parenteral administration of trehalose
    Patent number: 10493023
    Abstract: Disclosed is a method of treatment of a disease associated with abnormal protein aggregation comprising parenterally administering pharmaceutical formulations comprising trehalose. Also disclosed is an injectable aqueous pharmaceutical formulation comprising a therapeutically effective amount of trehalose.
    Type: Grant
    Filed: May 7, 2014
    Date of Patent: December 3, 2019
    Assignee: Seelos Therapeutics, Inc.
    Inventor: Dalia Megiddo